Cov2/Flu/RSV/MRSA reagents for Cambridge hospitals come from Cepheid
- Cambridge University Hospitals NHS Foundation Trust
- East of England
- Direct award
- 21 September 2026 to 20 September 2027
Cambridge University Hospitals NHS Foundation Trust is buying Cov2, flu, RSV and MRSA test reagents from Cepheid UK Limited.
The order covers the trust's expected volume for one year. Because the trust already rents Cepheid machines, it may need reagents for a further year.
The trust awarded the £816,150 contract directly to Cepheid in August 2026. With the extra year, it could run to September 2028.
Contract ends September 2027
- What
- PCR and molecular diagnostic platforms
- Supplier
- Cepheid UK Limited
- Value
- £816,150
- How it was bought
- Direct award
- Dates and next
- Sep 2026 to Sep 2027
- Being re-tendered now